AEHR insider sale: Danesh Fariba disposes 9,000 shares at $24.76–$24.87

Rhea-AI Filing Summary

Aehr Test Systems director Danesh Fariba reported the sale of 9,000 shares of common stock on 10/09/2025, disclosed on a Form 4 filed under Section 16. The filing shows two sales: 2,665 shares at $24.87 and 6,335 shares at $24.755. After these transactions the form reports beneficial ownership levels of 22,978 and 16,643 shares (the latter figure includes unvested restricted stock units). The Form 4 was signed by an attorney-in-fact on 10/10/2025, indicating timely reporting of insider disposition activity.

Positive

• Timely disclosure of insider sales via a filed Form 4
• Clear itemization of trade dates, prices, and resulting beneficial ownership
• Clarification that one balance includes unvested restricted stock units

Negative

• Director sold shares totaling 9,000 shares, reducing beneficial ownership
• Portion of remaining holdings are unvested and not immediately marketable

Insights

Corporate Governance Expert

Timely insider disposition disclosed by a company director.

The Form 4 records two separate sales totaling 9,000 shares by Director Danesh Fariba on 10/09/2025, with reported prices of $24.87 and $24.755. The filing also states remaining beneficial holdings, and notes that one reported balance includes unvested restricted stock units.

This is a routine Section 16 disclosure showing compliance with reporting rules; monitor subsequent filings for patterns in insider trading or changes in beneficial ownership over the next several reporting periods.

Equity Markets Analyst

Insider sold a modest block at roughly $24.76–$24.87; impact limited absent other signals.

Sales total 9,000 shares executed in two tranches at mid-$24 prices, reducing reported beneficial holdings to the disclosed balances. The note that one balance includes unvested restricted stock units clarifies that not all reported shares are freely tradable.

From a market perspective this single filing documents disposition but does not quantify proceeds or indicate intent; watch for additional activity or disclosures in upcoming Form 4s or company announcements within 30–90 days.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DANESH FARIBA

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CA 94539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)
	Director

3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/09/2025		S		2,665	D	$24.87	22,978	D
Common Stock	10/09/2025		S		6,335	D	$24.755	16,643(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AEHR (AEHR) director Danesh Fariba report on the Form 4?

The Form 4 reports that Danesh Fariba sold 9,000 shares on 10/09/2025 in two transactions at $24.87 and $24.755.

How many shares did Fariba own after the reported sales?

The filing shows beneficial ownership figures of 22,978 and 16,643 shares following the transactions; the latter figure includes unvested restricted stock units.

Does the Form 4 state that any reported shares are unvested?

Yes. The filing explains that one reported amount includes shares subject to unvested restricted stock units.

When was the Form 4 signed and filed?

The signature block shows the form was signed by an attorney-in-fact on 10/10/2025.

Are the exact sale prices disclosed?

Yes. The two transactions list prices of $24.87 and $24.755.